Mindray (NYSE:MR) said it’s agreed to a $105 million buyout of Zonare Medical Systems and its ultrasound technology.
Wall Street Beat
Abbott OKs $3B share buyback, dividend
Covidien CEO Almeida wants more from emerging markets | Wall Street Beat
Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.
Can C.R. Bard use a windfall to reignite growth?
Cyberonics gains Wall Street favor after beating Q4 outlook | Earnings Roundup
Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat
Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from a components and sub-assemblies company to a developer of full medical devices.
InVivo tackles debt, aims for up-listing to a national exchange
Massachusetts-based spinal devices maker InVivo Therapeutics (OTC:NVIV) hopes to up-list to a national stock exchange now that it’s has paid down significant debts.
Intuitive Surgical faces shareholder class action lawsuit
Shareholders of Intuitive Surgical (NSDQ:ISRG) late last month filed a class action lawsuit accusing the robot-assisted surgery giant and its executives of artificially inflating the company’s stock price with misleading statements and "disreputable" sales practices.
Edwards Lifesciences comes back down to earth – hard
Abbott, Boston Scientific pay almost no taxes in Ireland despite billions in profits | Wall Street Beat
Boston Scientific’s 5-part recipe for success
Medical device giant Boston Scientific (NYSE:BSX) has been soaring in recent months, with BSX shares up more than 50% since the start of 2013.